IP Library Granted Patent US 9,410,966
Granted Patent B2
US 9,410,966 · App. 14/156,175 · Granted Aug 9, 2016

Isotopic recoding for targeted tandem mass spectrometry

Inventors: Carolyn R. Bertozzi (Berkeley, CA); Brian P. Smart (Cupertino, CA); Austin A. Pitcher (Saint James, MN); Krishnan K. Palaniappan (Columbia, MO); Mark A. Breidenbach (New York, NY)
Assignee: The Regents of the University of California
G01N33/6848
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,410,966
App. No.
14/156,175
Granted
Aug 9, 2016
Kind
B2
Abstract

Aspects of the present disclosure include methods for detecting a low abundance protein and methods for identifying a site of N-glycosylation on a protein. In practicing methods according to certain embodiments, a eukaryotic cell is contacted with an isotopic labeling composition and isotopically labeled N-glycosylated peptides obtained from the eukaryotic cell are assessed by liquid chromatography-tandem mass spectrometry. A predetermined isotopic pattern in the mass spectrum is identified and amino acid sequences of the peptides containing the predetermined isotopic pattern are determined. Systems for identifying a predetermined isotopic pattern in mass spectra and determining amino acid sequences of peptides containing the predetermined isotopic pattern are also described.

Claims (27)

1. A method for identifying a site of N-glycosylation on a protein, the method comprising:

incubating a eukaryotic cell with an isotopic labeling composition comprising two or more different isotopic labels to obtain an isotopically labeled sample of N-glycosylated proteins;

enzymatically producing peptides from the isotopically labeled sample of N-glycosylated proteins to obtain an enzymatically treated sample of isotopically labeled peptides;

subjecting the enzymatically treated sample of isotopically labeled peptides to liquid-chromatography-tandem mass spectrometry;

identifying a predetermined isotopic pattern of the enzymatically treated, isotopically labeled sample of peptides in a mass spectrum at one or more retention times;

determining an amino acid sequence of an isotopically labeled peptide present at the one or more retention times;

and identifying the site of N-glycosylation on the isotopically labeled protein based on the determined amino acid sequence.

2. The method according to claim 1 , wherein the isotopic labels are N-acetyl-D-glucosamine, N-[1,2- 13 C 2 ]acetyl-D-glucosamine and N-[1,2- 13 C 2 ]acetyl-D-[1- 13 C; 15 N]glucosamine.

3. The method according to claim 2 , wherein the isotopic labeling composition comprises a stoichiometric ratio of 1:2:1 of N-acetyl-D-glucosamine, N-[1,2- 13 C 2 ]acetyl-D-glucosamine and N-[1,2- 13 C 2 ]acetyl-D-[1- 13 C; 15 N]glucosamine.

4. The method according to claim 1 , wherein enzymatically producing peptides comprises contacting the N-glycosylated proteins with trypsin, Lys-C, Arg-N or chymotrypsin.

5. The method according to claim 1 , wherein identifying a predetermined isotopic pattern comprises identifying a 1:2:1 peak intensity ratio in the mass spectrum.

6. The method according to claim 1 , wherein the method further comprises generating an inclusion list of peptides having a mass spectrum that contains the predetermined isotopic pattern.

7. The method according to claim 6 , wherein the method further comprises determining an amino acid sequence for each of the peptides on the inclusion list.

8. A method for detecting a low-abundance protein in a biological sample, the method comprising:

incubating a eukaryotic cell with an isotopic labeling composition comprising two or more different isotopic labels;

subjecting an isotopically labeled biological sample obtained from the eukaryotic cell to liquid-chromatography-tandem mass spectrometry; and

identifying a predetermined isotopic pattern in a mass spectrum at one or more retention times to thereby detect the presence of the low-abundance protein in the biological sample.

9. The method according to claim 8 , wherein the isotopic labels are N-acetyl-D-glucosamine, N-[1,2- 13 C 2 ]acetyl-D-glucosamine and N-[1,2- 13 C 2 ]acetyl-D-[1- 13 C; 15 N]glucosamine.

10. The method according to claim 9 , wherein the isotopic labeling composition comprises a stoichiometric ratio of 1:2:1 of N-acetyl-D-glucosamine, N-[1,2- 13 C 2 ]acetyl-D-glucosamine and N-[1,2- 13 C 2 ]acetyl-D-[1- 13 C; 15 N]glucosamine.

11. The method according to claim 8 , wherein the isotopically labeled biological sample obtained from the eukaryotic cell comprises N-glycosylated proteins.

12. The method according to claim 11 , wherein the N-glycosylated proteins comprise the isotopic labels.

13. The method according to claim 11 , wherein the method further comprises producing peptides from the N-glycosylated proteins.

14. The method according to claim 13 , wherein producing peptides comprises contacting the N-glycosylated proteins with trypsin, Lys-C, Arg-N or chymotrypsin.

15. The method according to claim 8 , wherein identifying a predetermined isotopic pattern comprises identifying a 1:2:1 peak intensity ratio in the mass spectrum.

16. The method according to claim 8 , wherein the method further comprises determining an amino acid sequence of the low abundance protein.

17. The method according to claim 8 , wherein the method further comprises generating an inclusion list of peptides having a mass spectrum that contains the predetermined isotopic pattern.

18. The method according to claim 17 , wherein the method further comprises determining an amino acid sequence for each of the peptides on the inclusion list.

Assignments (3)
CONFIRMATORY LICENSE Recorded Mar 11, 2015
From: UNIVERSITY OF CALIFORNIA BERKELEY
To: US ARMY, SECRETARY OF THE ARMY
Reel/Frame 035176/0792 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2014
From: BERTOZZI, CAROLYN R.; SMART, BRIAN P.; PITCHER, AUSTIN A.; PALANIAPPAN, KRISHNAN K.; BREIDENBACH, MARK A.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 033604/0725 →
CONFIRMATORY LICENSE Recorded Feb 25, 2014
From: UNIVERSITY OF CALIFORNIA BERKELEY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 032332/0752 →
Continuity (2)
Provisional Application 61753774 · Jan 17, 2013
Related Publication 20140199716A1 · Jul 17, 2014